{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:08:17Z","timestamp":1789132097674,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008035","name":"Njurfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008035","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010664","name":"Martin Rinds Stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010664","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013964","name":"Stiftelsen Stig och Gunborg Westman","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013964","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bogetic Research Fellowship, Monash Health"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01DK115534"],"award-info":[{"award-number":["R01DK115534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Stockholm","award":["20250416"],"award-info":[{"award-number":["20250416"]}]},{"name":"ALF medicine","award":["FoUI-986028"],"award-info":[{"award-number":["FoUI-986028"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Women with preeclampsia had a higher risk of incident albuminuria &gt;300 mg\/g, eGFR &lt;60 ml\/min per 1.73 m\n                            <jats:sup>2<\/jats:sup>\n                            , or the composite outcome.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The higher risk extended across multiple outcomes, including CKD diagnoses and nephrology referrals.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Despite these risks, postpartum monitoring of kidney function was infrequent, limiting opportunities for early detection and intervention.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preeclampsia, a systemic hypertensive disorder of pregnancy, has been associated with the risk of kidney failure, an outcome that may take decades to develop. However, its association with early kidney disease, which could be targeted for intervention, remains underexplored. Here, we quantified the risk of CKD, defined by laboratory markers of kidney damage, in women who had a pregnancy complicated by preeclampsia versus a pregnancy without preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a population-based cohort study in Stockholm, Sweden, using inverse probability of treatment weights to minimize confounding. All nulliparous women who had at least one pregnancy ending in live or stillbirth between January 1, 2006, and December 31, 2020, were identified, excluding preexisting hypertension, diabetes, or CKD. Primary outcomes were (\n                      <jats:italic toggle=\"yes\">1<\/jats:italic>\n                      ) albuminuria defined by urine albumin-creatinine ratio &gt;300 mg\/g, (\n                      <jats:italic toggle=\"yes\">2<\/jats:italic>\n                      ) eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , and (\n                      <jats:italic toggle=\"yes\">3<\/jats:italic>\n                      ) composite of albuminuria &gt;300 mg\/g and\/or eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 171,693 pregnancies (170,192 women: mean [SD] age, 29 [5] years), of whom 10,538 (6%) had at least one pregnancy complicated by preeclampsia. During a median follow-up of 7.0 years (interquartile range, 3.3\u201310.5), albuminuria &gt;300 mg\/g occurred after 775 pregnancies (0.5%), eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      occurred after 248 pregnancies (0.1%), and the composite outcome occurred after 985 pregnancies (0.6%). Incidence rates per 1000 person-years were higher after preeclampsia versus no preeclampsia for albuminuria &gt;300 mg\/g (1.53 versus 0.57), eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      (0.52 versus 0.18), and the composite outcome (2.00 versus 0.73). Weighted hazard ratios were 2.53 (95% confidence interval [CI], 2.04 to 3.13) for albuminuria &gt;300 mg\/g, 2.18 (95% CI, 1.49 to 3.19) for eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , and 2.43 (95% CI, 2.01 to 2.95) for the composite outcome. In the first postpartum year, 2080 (20%) and 1043 (10%) of women with preeclampsia had serum creatinine or urine albumin testing, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preeclampsia was associated with a higher risk of laboratory signs of early kidney damage. There were low rates of postpartum kidney function monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001001","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:00:21Z","timestamp":1767373221000},"page":"1524-1534","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Laboratory Signs of CKD after Preeclampsia"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-1813","authenticated-orcid":false,"given":"Jennifer H.","family":"Yo","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Faculty of Medicine Nursing and Health Sciences, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-344X","authenticated-orcid":false,"given":"Yuanhang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6019-9342","authenticated-orcid":false,"given":"Aurora","family":"Caldinelli","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6023","authenticated-orcid":false,"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[{"name":"Department of Population Health, New York University Grossman School of Medicine, New York, New York"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-7921","authenticated-orcid":false,"given":"Kate","family":"Bramham","sequence":"additional","affiliation":[{"name":"Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-4009","authenticated-orcid":false,"given":"Giorgina B.","family":"Piccoli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centre Hospitalier Le Mans, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-2024","authenticated-orcid":false,"given":"Juan-Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-1895","authenticated-orcid":false,"given":"Anna Sara","family":"Oberg","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"B1-20260826","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"6","key":"B2-20260826","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","author":"Espinoza","year":"2020","journal-title":"Am Coll Obstet Gynecol."},{"issue":"6","key":"B3-20260826","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/heartjnl-2014-306571","article-title":"Long-term maternal atherosclerotic morbidity in women with pre-eclampsia","volume":"101","author":"Kessous","year":"2015","journal-title":"Heart."},{"issue":"5","key":"B4-20260826","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.22107","article-title":"Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis","volume":"57","author":"Dall\u2019Asta","year":"2021","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"76","key":"B5-20260826","first-page":"168","article-title":"Clinical management guidelines for obstetrician \u2013 gynecologists - gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"24","key":"B6-20260826","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1161\/CIR.0000000000000582","article-title":"Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists","volume":"137","author":"Brown","year":"2018","journal-title":"Circulation."},{"issue":"11","key":"B7-20260826","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"issue":"25","key":"B8-20260826","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"issue":"8","key":"B9-20260826","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and end-stage renal disease","volume":"359","author":"Viske","year":"2008","journal-title":"N Engl J Med."},{"key":"B10-20260826","doi-asserted-by":"crossref","first-page":"l1516","DOI":"10.1136\/bmj.l1516","article-title":"Pre-eclampsia and risk of later kidney disease: nationwide cohort study","volume":"365","author":"Kristensen","year":"2019","journal-title":"BMJ."},{"issue":"12","key":"B11-20260826","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","article-title":"Prevalence and recognition of chronic kidney disease in Stockholm healthcare","volume":"31","author":"Gasparini","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"4S","key":"B12-20260826","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"6","key":"B14-20260826","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2009.12.036","article-title":"Kidney disease after preeclampsia: a systematic review and meta-analysis","volume":"55","author":"Mcdonald","year":"2010","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B15-20260826","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2019.03.033","article-title":"A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia","volume":"96","author":"Covella","year":"2019","journal-title":"Kidney Int."},{"issue":"6","key":"B16-20260826","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.ajkd.2023.04.010","article-title":"Preeclampsia and long-term kidney outcomes: an observational cohort study","volume":"82","author":"Srialluri","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B17-20260826","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/joim.13418","article-title":"The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care","volume":"291","author":"Carrero","year":"2022","journal-title":"J Intern Med."},{"issue":"806-808","key":"B19-20260826","first-page":"1453","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Von","year":"2007","journal-title":"BMJ."},{"key":"B20-20260826","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health."},{"issue":"9","key":"B21-20260826","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"6","key":"B22-20260826","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/M20-0529","article-title":"Conversion of urine protein\u2013creatinine ratio or urine dipstick protein to urine albumin\u2013creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant\u2013based meta-analysis","volume":"173","author":"Sumida","year":"2020","journal-title":"Ann Intern Med."},{"issue":"4","key":"B23-20260826","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores","volume":"54","author":"Normand","year":"2001","journal-title":"J Clin Epidemiol."},{"issue":"15","key":"B24-20260826","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med."},{"issue":"26","key":"B25-20260826","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1002\/sim.8355","article-title":"Avoiding pitfalls when combining multiple imputation and propensity scores","volume":"38","author":"Granger","year":"2019","journal-title":"Stat Med."},{"issue":"5","key":"B27-20260826","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s40620-021-01134-7","article-title":"Postnatal assessment for renal dysfunction in women with hypertensive disorders of pregnancy: a prospective observational study","volume":"34","author":"Kountouris","year":"2021","journal-title":"J Nephrol."},{"issue":"1","key":"B28-20260826","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1038\/s41598-021-92078-2","article-title":"An observational claims data analysis on the risk of maternal chronic kidney disease after preterm delivery and preeclampsia","volume":"11","author":"Goetz","year":"2021","journal-title":"Sci Rep."},{"issue":"3","key":"B29-20260826","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1503\/cmaj.120230","article-title":"Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study","volume":"185","author":"Wang","year":"2013","journal-title":"CMAJ."},{"issue":"3","key":"B30-20260826","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40620-017-0390-1","article-title":"A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy","volume":"30","author":"Piccoli","year":"2017","journal-title":"J Nephrol."},{"issue":"13","key":"B31-20260826","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA."},{"issue":"5","key":"B32-20260826","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","article-title":"Cost-effectiveness of primary screening for CKD: a systematic review","volume":"63","author":"Komenda","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B33-20260826","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/M22-3228","article-title":"Population-wide screening for chronic kidney disease: a cost-effectiveness analysis","volume":"176","author":"Cusick","year":"2023","journal-title":"Ann Intern Med."},{"issue":"1","key":"B34-20260826","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","article-title":"The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"99","author":"Shlipak","year":"2021","journal-title":"Kidney Int."},{"issue":"16","key":"B35-20260826","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.123.068524","article-title":"Accelerated risk-based implementation of guideline-directed medical therapy for type 2 diabetes and chronic kidney disease","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation."},{"issue":"1","key":"B36-20260826","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"B37-20260826","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.kint.2023.04.030","article-title":"A kidney-centric view of pre-eclampsia through the kidney-placental bidirectional lens","volume":"104","author":"Garovic","year":"2023","journal-title":"Kidney Int."},{"issue":"4","key":"B38-20260826","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2007.02.007","article-title":"Urinary podocyte excretion as a marker for preeclampsia","volume":"196","author":"Garovic","year":"2007","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"B39-20260826","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ki.2014.17","article-title":"Advances in the pathophysiology of pre-eclampsia and related podocyte injury","volume":"86","author":"Craici","year":"2014","journal-title":"Kidney Int."},{"issue":"1","key":"B40-20260826","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ekir.2018.10.012","article-title":"Renal complications in pregnancy preceding glomerulonephropathy diagnosis","volume":"4","author":"Oliverio","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"2","key":"B41-20260826","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"B42-20260826","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension."},{"issue":"2","key":"B43-20260826","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.kint.2022.10.027","article-title":"Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting","volume":"103","author":"Mazhar","year":"2023","journal-title":"Kidney Int."},{"issue":"5","key":"B44-20260826","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40620-022-01546-z","article-title":"Prevalence of chronic kidney disease in women of reproductive age and observed birth rates","volume":"36","author":"Vrijlandt","year":"2023","journal-title":"J Nephrol."},{"issue":"5","key":"B45-20260826","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.07911109","article-title":"Pregnancy and chronic kidney disease: a challenge in all CKD stages","volume":"5","author":"Piccoli","year":"2010","journal-title":"Clin J Am Soc Nephrol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:05:51Z","timestamp":1787745951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001001","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}